Insulin-like Growth Factor-1 (IGF-1) Inversely Regulates Atrophy-induced Genes via the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (PI3K/Akt/mTOR) Pathway
Top Cited Papers
Open Access
- 1 January 2005
- journal article
- Published by Elsevier BV
- Vol. 280 (4), 2737-2744
- https://doi.org/10.1074/jbc.m407517200
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Conditional Activation of Akt in Adult Skeletal Muscle Induces Rapid HypertrophyMolecular and Cellular Biology, 2004
- The molecular basis of skeletal muscle atrophyAmerican Journal of Physiology-Cell Physiology, 2004
- The IGF-1/PI3K/Akt Pathway Prevents Expression of Muscle Atrophy-Induced Ubiquitin Ligases by Inhibiting FOXO Transcription FactorsMolecular Cell, 2004
- High-throughput engineering of the mouse genome coupled with high-resolution expression analysisNature Biotechnology, 2003
- Signalling pathways that mediate skeletal muscle hypertrophy and atrophyNature, 2003
- The phosphatidylinositol 3-Kinase–AKT pathway in human cancerNature Reviews Cancer, 2002
- The Phosphoinositide 3-Kinase PathwayScience, 2002
- Identification of Ubiquitin Ligases Required for Skeletal Muscle AtrophyScience, 2001
- What do we really know about the ubiquitin-proteasome pathway in muscle atrophy?Current Opinion in Clinical Nutrition and Metabolic Care, 2001
- Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase BNature, 1995